Low pretreatment PNI was associated with poorer OS and PFS in HCC patients receiving ICIs. These findings suggest that PNI may be a promising and practical prognostic marker in this setting. However, prospective studies are needed to validate its utility before it can be considered an established biomarker.
Peng et al. (Sat,) studied this question.